Lars G. Hemkens, Heiner C. Bucher
Status: Abgeschlossen Dauer: Dez. 2013 - Okt. 2016
Off-label use of a drug refers to any application that is in deviation from the use approved by a drug licensing agency. Preferably off-label drug use should be considered when there is no alternative on-label treatment for a patient’s condition e.g. in case of serious conditions if approved drugs have failed. Off-label use is highly prevalent in medical practice but often not supported by good evidence. In this meta-epidemiological analysis the overall benefits and harms of off-label use is evaluated in comparison to licenced drugs used for the same indication.